Change Location × Worldwide

    Recent Locations

      Stuart Lipton, M.D., Ph.D. Schedule and Appearances


      • Stuart Lipton, M.D., Ph.D. Photo #1
      1 of 1
      Professor, researcher on neurodegenerative dieases, Burnham Institute, San Diego
      From the official site: Stuart Lipton went to Cornell University, entered an M.D./Ph.D. Program at the University of Pennsylvania (UPENN), and completed his M.D. at UPENN and his Ph.D. with John Dowling at Harvard in 1977. He was then a medical intern and neurology resident at Harvard and a post... read more
      More About Stuart Lipton, M.D., Ph.D.

      Recommendations Similar to Stuart Lipton, M.D., Ph.D.

      Receive alerts & never miss a show | Manage Favorites

      MORE INFO ABOUT Stuart Lipton, M.D., Ph.D.

      Bio

      From the official site:


      Stuart Lipton went to Cornell University, entered an M.D./Ph.D. Program at the University of Pennsylvania (UPENN), and completed his M.D. at UPENN and his Ph.D. with John Dowling at Harvard in 1977. He was then a medical intern and neurology resident at Harvard and a postdoctoral fellow of Torsten Wiesel when Wiesel won the Nobel prize in 1981. In 1997, after spending 15 years on the staff of Children's Hospital in Boston, Dr. Lipton moved to Brigham and Women's Hospital to become Chief of the CNS Research Institute at Harvard Medical School. Dr. Lipton was recruited to the Burnham Institute in September 1999 as Professor and Director of the Del E.Webb Center for Neuroscience and Aging Research. At that time he initiated the Center's program on Degenerative Disease Research.


      Dr. Lipton has been interested in the role of ion channels in neuronal outgrowth, plasticity and survival. His group has developed several clinically-tolerated drugs to prevent neuronal damage and apoptosis due to excessive stimulation of ion channels by excitatory neurotransmitters acting at the NMDA subtype of glutamate receptor in the brain. These drugs may be useful for several neurological disorders, including stroke, spinal cord and head injury, glaucoma, Huntington's disease, and AIDS dementia. Drugs developed in his laboratory are currently in advanced clinical trials. Recently, Dr. Lipton was asked to deliver a Nobel Foundation Lecture at the Karolinska Institute and a plenary lecture at the National Academy of Sciences on the topic of NMDA open-channel blockers and nitric oxide-related drugs for the treatment of AIDS dementia, a field in which he continues to be among the leaders.

      Categories: Science

      Claim your performer profile on eventful to:
      • Find out where you're in demand and route your tours
      • Get stats and demographic data on your fans
      • Send messages to your fans
      • Add your events and edit your profile
      Get Started Now!